NCT01549106View on ClinicalTrials.gov

IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

IPI-145

Single ascending dose up to 6 cohorts; multiple ascending dose up to 4 cohorts; food effect arm; ketoconazole drug interaction study

DRUG

Placebo

Single ascending dose up to 6 cohorts; multiple ascending dose up to 4 cohorts; food effect arm

Trial Locations (1)

9470 AE

PRA International, Zuidlaren

All Listed Sponsors
lead

SecuraBio

INDUSTRY

NCT01549106 - IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study | Biotech Hunter | Biotech Hunter